Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELIMUMAB vs BEMPEGALDESLEUKIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELIMUMAB vs BEMPEGALDESLEUKIN: Safety Overview

Metric BELIMUMAB BEMPEGALDESLEUKIN
Total FAERS Reports 26,773 174
Deaths Reported 788 22
Death Rate 2.9% 12.6%
Hospitalizations 3,771 159
Average Patient Age 47.2 yrs 64.9 yrs
% Female Patients 93.3% 23.6%
Manufacturer GlaxoSmithKline LLC N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A